List of SBIR/STTR awards granted to NuvOx Pharma
NuvOx PharmaName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to NuvOx Pharma in September, 2021 for $478,050.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS124450-01 | Phase I | 478,050 | September 15, 2021 | |||||||
A SBIR Phase I contract was awarded to NuvOx Pharma in December, 2017 for $143,988.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS105295-01 | Phase I | 143,988 | December 1, 2017 | |||||||
A SBIR Phase II contract was awarded to NuvOx Pharma in July, 2018 for $1,996,751.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA203090-02 | Phase II | 1,996,751 | July 12, 2018 | |||||||
A STTR Phase I contract was awarded to NuvOx Pharma in September, 2016 for $298,820.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA213544-01 | Phase I | 298,820 | September 19, 2016 | |||||||
A SBIR Phase I contract was awarded to NuvOx Pharma in April, 2017 for $317,743.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL137545-01 | Phase I | 317,743 | April 1, 2017 | |||||||
A SBIR Phase II contract was awarded to NuvOx Pharma in September, 2017 for $1,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA144817-03 | Phase II | 1,000,000 | September 12, 2017 | |||||||
A STTR Phase I contract was awarded to NuvOx Pharma in September, 2016 for $243,164.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41HD089823-01 | Phase I | 243,164 | September 1, 2016 | |||||||
A STTR Phase I contract was awarded to NuvOx Pharma in March, 2016 for $297,786.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA203090-01 | Phase I | 297,786 | March 15, 2016 | |||||||
A SBIR Phase I contract was awarded to NuvOx Pharma for $204,360.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA144817-01 | Phase I | 204,360 | ||||||||
A SBIR Phase I contract was awarded to NuvOx Pharma for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43HL140045 | Phase I | 225,000 | ||||||||
A SBIR Phase II contract was awarded to NuvOx Pharma in April, 2023 for $301,366.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1U44NS130589-01 | Phase II | 301,366 | April 15, 2023 |
